The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C

Journal Title: One Health & Risk Management - Year 2020, Vol 1, Issue 1

Abstract

Introduction. Viral hepatitis C (HCV) is a significant global health problem. The risk of developing chronic HCV is up to 80% of patients, of whom 10-20% can develop liver cirrhosis or hepatocellular carcinoma which can lead to death. Treatment with direct-acting antiviral agents (DAAs) contributes to a sustained virological response (SVR) in 97-99% of cases. Material and methods. The study was conducted on 206 patients with chronic HCV who underwent two generic antiviral agent therapies: group I (103) – Sofosbuvir 400 mg + Ledipasvir 80 mg, whereas group II (103) – Sofosbuvir 400 mg + Daclatasvir 60 mg orally, once a day, for 12 weeks. The assessment of hepatitis C virus RNA and genotype, as well as the degree of hepatic fibrosis by Fibroscan, biochemical and complete blood count (CBC) indices were carried out. Results. The study results showed high efficacy of the generic DAAs treatment in patients with chronic HCV over 12 weeks. The SVR rate made up 90.3% in Sofosbuvir + Ledipasvir therapy and 86.4% – in Sofosbuvir + Daclatasvir. Similar treatment response was recorded in naive patients and those who previously underwent unsuccessful treatment with Pegylated Interferon and Ribavirin. The DAAs treatment showed the following minor adverse reactions: asthenia, headache, sleep dCiosncoclnutsiniounatsi.on. disorder, and nausea, which did not require treatment The 12-week course of DAAs therapy exhibited high SVR rate in both chronic HCV naive patients and those previously treated with Pegylated Interferon and Ribavirin.

Authors and Affiliations

Irina RUSU*, Liliana HODOROGEA, Tiberiu HOLBAN

Keywords

Related Articles

Current issues related to access and use of information on ex situ conservation of plant genetic resources in the Republic of Moldova

Introduction. The rapid development of information technologies has provided challenges and opportunities for effective documentation of plant genetic resources (PGR). Access to information on PGR is essential for their...

Case report: acute liver failure induced by paracetamol toxicity

Introduction. Paracetamol is the most commonly used drug across Western Europe and North America. There is no such trend of using Paracetamol in the Republic of Moldova, thus overdose cases are extremely rare. The mechan...

Retrospective study on the prevalence of COVID-19 confirmed cases and evidence of gender bias in Libya

Introduction. To stop SARS-CoV-2 from spreading, it's crucial to have a solid understanding of the baseline characteristics of demographic variables, clinical symptoms, and comorbidity so that quarantining and testing pr...

The role of boron in prevention of osteoarticular diseases and its distribution in the Republic of Moldova

Introduction. Boron is a trace mineral that is supposed to be essential for human health. Organic plant based boron compounds are highly bioavailable for humans and can positively influence minerals such as calcium, phos...

Biochemical composition changes of gram-negative microorganisms under the action of new chemical compounds

Introduction. It is known that the enzymes catalase (CT) and superoxide dismutase (SOD) are actively involved in protecting cells of microbial pathogens against the biochemical factors produced by macrophages in vivo, in...

Download PDF file
  • EP ID EP683644
  • DOI 10.5281/zenodo.3700945
  • Views 268
  • Downloads 0

How To Cite

Irina RUSU*, Liliana HODOROGEA, Tiberiu HOLBAN (2020). The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C. One Health & Risk Management, 1(1), -. https://europub.co.uk/articles/-A-683644